IMPAX LABS: Expects Injunction Ruling Over Marketing of Riluzole
February 2, 2009
The U.S. District Court for the District of Delaware is expected to enter a permanent injunction enjoining Impax Laboratories, Inc. from marketing Riluzole 50mg tablets until the expiration of Aventis…